中医药调节免疫微环境延缓肝癌复发转移
Traditional Chinese Medicine Regulates Immune Microenvironment and Delays the Recurrence and Metastasis of Hepatocellular Carcinoma

作者: 徐汉辰 , 宋海燕 , 季 光 :上海中医药大学脾胃病研究所;上海中医药大学附属龙华医院消化内科; 杨金坤 :上海中医药大学附属龙华医院肿瘤科;

关键词: 肝癌免疫微环境复发和转移Hepatocellular Carcinoma Immune Microenvironment Recurrence and Metastasis

摘要: 肝癌是临床上最常见的恶性肿瘤之一,手术、介入治疗及近年开展的立体定向适形放射治疗等均有良好的近期疗效,但都不能解决肝癌的复发和转移问题。中医药已经成为肿瘤辅助治疗的主要手段,有效地改善了肿瘤患者的症状、延长生存期、提高生活质量、延缓复发和转移。本文在简述肝癌的复发转移与机体免疫功能的关系基础上,总结近五年中医药调节免疫微环境延缓肝癌复发转移的研究现状。

Abstract: Hepatocellular carcinoma is one of the most common malignant tumor in clinical. Surgery, interventional therapy and stereotactic conformal radiotherapy in recent years all have good short-term curative effects, but cannot solve the problem of recurrence and metastasis of hepatocellular carcinoma. Traditional Chinese medicine has become the principal means of adjuvant treatment of cancer, which effectively improves the symptoms of cancer patients, pro- longs the survival time, improves the life quality and delays the recurrence and metastasis. In this article, on the basis of outlining the relationship between the recurrence and metastasis of hepatocellular carcinoma and the immunological function, we summarize the current situation of traditional Chinese medicine regulating immune microenvironment and delaying the recurrence and metastasis of hepatocellular carcinoma in recent five years.

文章引用: 徐汉辰 , 宋海燕 , 杨金坤 , 季 光 (2013) 中医药调节免疫微环境延缓肝癌复发转移。 中医学, 2, 30-34. doi: 10.12677/TCM.2013.23008

参考文献

[1] 陆再英, 钟南山. 内科学[M]. 北京: 人民卫生出版社, 2008: 457-462.

[2] 郭武华, 张吉翔. 肝癌综合治疗的现状[J]. 世界华人消化杂志, 2008, 16: 2199-2203.

[3] 卢欣, 赵海涛, 毛一雷等. 肝细胞肝癌患者术后早期复发情况[J]. 中国医学科学院学报, 2008, 30(4): 415-419.

[4] 李朝军. 刘嘉湘教授治疗肝癌经验[J]. 山西中医杂志, 2009, 25(12): 9-10.

[5] 曹继刚, 邱幸凡, 陈月雀等. 原发性肝癌的基本病机及治则探讨[J]. 中医药学报, 2008, 36(4): 28-29.

[6] 黄学武, 代兴斌. 癌毒诊治探讨[J]. 新中医, 2008, 40: 6-7.

[7] 张金峰. 凌昌全癌毒学说运用经验[J]. 中医杂志, 2008, 49(8): 693.

[8] 贾小强, 黄乃健, 邱辉忠. 恶性肿留转移的中医病机研究恩路和策略[J]. 中医药临床杂志, 2005, 17(1): 60-61.

[9] 顾健人, 杨胜利. 要用系统性疾病的观念重新认识癌症[J]. 中华医学杂志, 2005, 85: 505-507.

[10] 何维. 医学免疫学[M]. 北京: 人民卫生出版社, 2005: 348.

[11] D. Gabrilovich. Immunosuppressive strategies that are mediated by tumor cells. Annual Review of Immunology, 2007, 25: 267- 296.

[12] R. M. Hershberg, L. F. Mayer. Antigen processing and presenta- tion by intestinal epithelial cells-polarity and complexity. Immu- nology Today, 2000, 21(3): 123-128.

[13] 白广德, 练祖平, 黄丁平等. 中西医结合防治中晚期肝癌复发转移的临床研究[J]. 吉林中医药杂志, 2010, 30(8): 674- 675.

[14] 白广德, 练祖平, 黄丁平等. 自拟益肝方配合西医治疗中晚期肝癌30例[J]. 陕西中医, 2008, 29(1): 16-19.

[15] 黄智芬, 黎汉忠, 施智严. 健脾消积口服液结合西药治疗晚期肝癌40例的临床观察[J]. 中国中西医结合杂志, 2003, 23(3): 192-194.

[16] V. Chew, C. Tow, M. Teo, et al. Inflammatory tumour microen- vironment is associated with superior survival in hepatocellular carcinoma patients. Journal of Hepatology, 2010, 52(3): 370- 379.

[17] L. Liu,J. Jia, G. Zeng, et al. Studies on immunoregulatory and anti-tumor activities of a polysaccharide from salvia miltiorrhiza Bunge. Carbohydrate Polymers, 2013, 92: 479-483.

[18] X.-N. Wang, X. Han, L.-N. Xu, et al. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine, 2008, 15(12): 1062-1068.

[19] G.-P. Sun,H. Wang, S.-P. Xu, et al. Anti-tumor effects of pae- onol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-α produc- tion. European Journal of Pharmacology, 2008, 584: 246-252.

[20] G. Dranoff, R. C. Mulligan. Gene transfer as cancer therapy. Ad- vances in Immunology, 1995, 58: 417-454.

[21] X. Ding, F. S. Zhu, S. G. Gao, et al. Purification, antitumour and immunomodulatory activity of water-extractable and alkali-ex- tractable polysaccha-rides from Solanum nigrum L. Food Chem- istry, 2012, 131(2): 677-684.

[22] H. Li, M. Sun, J. Xu, et al. Immunological response in H22 transplanted mice undergoing Aconitum coreanum polysaccha- ride treatment. International Journal of Biological Macromole- cules, 2013, 55: 295-300.

[23] X. H. Shen, N. Li, H. Li, et al. Increased prevalence of regula- tory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 2010, 136(11): 1745-1754.

[24] N. Kobayashi, N. Hiraoka, W. Yamagami, et al. FOXP3 + regu- latory T cells affect the development and progression of hepato- carcinogenesis. Clinical Cancer Research, 2007, 13(3): 902-911.

[25] Q. Li, J.-M. Bao, X.-L. Li, et al. Inhibiting effect of Astragalus polysaccharides on the functions of CD4+ CD25 high Treg cells in the tumor microenvironment of human hepatocellular carci- noma. Chinese Medical Journal 2012; 125(5): 786-793.

[26] Y. Lu, B.-Y. Zhang, Z.-X. Jia, et al. Hepatocellular carcinoma HepG2 cell apoptosisand caspase-8 and Bcl-2 expression in- duced by injectable seed extract of Coix lacryma-jobi. Hepatobiliary & Pancreatic Diseases International, 2011, 3(10): 303- 307.

[27] Z. X. Cheng, K. M. Wang, J. Wei, et al. Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells. Phy- tomedicine, 2010, 17(13): 1000-1005.

[28] D.-C. Chao, L.-J. Lin, S.-T. Kao, et al. Inhibitory effects of Zuo- Jin-Wan and it’s alkaloidal ingredients on activator protein 1, nuclear factor-κB, and cellular transformation in HepG2 cells. Fitoterapia, 2011, 82(4): 696-703.

[29] 汤钊酋. 现代肿瘤学[M]. 上海: 复旦大学出版社, 2011: 288.

[30] 刘彦平, 李积东. 枸杞多糖对小鼠NK细胞和白细胞活性的免疫调节作用[J]. 青海医学院学报, 2001, 22(1): l-2.

[31] 廉晓红, 李德山, 窦玉琴等. 香茅草提取物的免疫调节作用与肿瘤抑制作用[J]. 沈阳药科大学学报, 2005, 22(4): 295- 297.

[32] 山广志, 凌仕良. 应用补阳还五汤维持治疗肝癌术后患者35例[J]. 中国中医药科技, 2011, 18(2): 164-165.

分享
Top